BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025.
World J Cardiol. Oct 26, 2025; 17(10): 111598
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.111598
Table 2 Catheter-based interventions for pulmonary embolism
Therapy type
Key devices
Mechanism of action
Evidence and trials
Benefits
Complications/risks
CDTStandard/perforated infusion catheters (Uni-Fuse, Cragg-McNamara)Local thrombolytic drug infusion into thrombusSupported by ULTIMA, SEATTLE II, OPTALYSE PELower bleeding risk than systemic thrombolysisRequires prolonged infusion, potential bleeding
Ultrasound-assisted thrombolysisEKOS (EkoSonic)Ultrasound energy enhances thrombolytic penetrationSame trials as CDT, plus KNOCOUT PE, SUNSET sPEEffective RV-to-left ventricle ratio reduction, low bleedingVariable efficacy vs standard catheter-directed thrombolysis, longer duration
Mechanical thrombectomy-FlowTrieverFlowTriever (Inari)Aspiration with large-bore catheters and clot disruption tipFLARE, FLASH registryImmediate hemodynamic improvement, low mortalityBlood loss, procedural complexity
Mechanical thrombectomy-IndigoIndigo system (Penumbra)Automated aspiration using suction pump and separator wireEXTRACT-PE, STRIKE-PERapid improvement in RV strain, symptom reliefDevice-related events (rare), training required
Pharmaco-mechanical thrombectomyCombined use of thrombolytics and mechanical devicesDual action: Clot lysis and mechanical removalPEERLESS TrialImproved outcomes over thrombolysis in some studiesNeed for precise patient selection, limited long-term data


Write to the Help Desk